• 44184 Citations
  • 102 Scopus h-Index
1988 …2020

Research output per year

If you made any changes in Pure these will be visible here soon.

Research Output

Filter
Comment/debate
2019
Open Access

Correction to: The evaluation of monoclonal gammopathy of renal significance: a consensus report of the International Kidney and Monoclonal Gammopathy Research Group (Nature Reviews Nephrology, (2019), 15, 1, (45-59), 10.1038/s41581-018-0077-4)

Leung, N., Bridoux, F., Batuman, V., Chaidos, A., Cockwell, P., D’Agati, V. D., Dispenzieri, A., Fervenza, F. C., Fermand, J. P., Gibbs, S., Gillmore, J. D., Herrera, G. A., Jaccard, A., Jevremovic, D., Kastritis, E., Kukreti, V., Kyle, R. A., Lachmann, H. J., Larsen, C. P., Ludwig, H. & 13 others, Markowitz, G. S., Merlini, G., Mollee, P., Picken, M. M., Rajkumar, S. V., Royal, V., Sanders, P. W., Sethi, S. M., Venner, C. P., Voorhees, P. M., Wechalekar, A. D., Weiss, B. M. & Nasr, S. H., Jan 1 2019, In : Nature Reviews Nephrology. 15, 2, 1 p.

Research output: Contribution to journalComment/debate

1 Scopus citations
2018
20 Scopus citations
2017

The yin and yang of autophagy in AL amyloidosis

Dispenzieri, A., Apr 13 2017, In : Blood. 129, 15, p. 2044-2045 2 p.

Research output: Contribution to journalComment/debate

2 Scopus citations
2014
2013

Clinical Reasoning: A 40-year-old man with CIDP-like illness resistant to treatment

Lahoria, R., Karam, C., Dispenzieri, A. & Dyck, P. J. B., Sep 3 2013, In : Neurology. 81, 10, p. e65-e70

Research output: Contribution to journalComment/debate

1 Scopus citations
2012

Long-term outcomes after autologous stem cell transplantation in patients with POEMS syndrome

Dispenzieri, A., Nov 1 2012, In : Clinical Advances in Hematology and Oncology. 10, 11, p. 744-746 3 p.

Research output: Contribution to journalComment/debate

2 Scopus citations

Ushering in a new era for POEMS

Dispenzieri, A., Jun 16 2011, In : Blood. 117, 24, p. 6405-6406 2 p.

Research output: Contribution to journalComment/debate

17 Scopus citations

Serum free light chain ratio is an independent risk factor for progression in monoclonal gammopathy of undetermined significance (Blood (2005) 106 (812-817))

Rajkumar, S. V., Kyle, R. A., Therneau, T. M., Melton, L. J., Bradwell, A. R., Clark, R. J., Larson, D. R., Plevak, M. F., Dispenzieri, A. & Katzmann, J. A., Feb 1 2010, In : British journal of haematology. 148, 3, 1 p.

Research output: Contribution to journalComment/debate

2008

Biology, treatment, and time

Dispenzieri, A., Oct 15 2008, In : Blood. 112, 8, p. 2999-3000 2 p.

Research output: Contribution to journalComment/debate

2007

Corrigendum to "Quantitative analysis of clonal bone marrow CD19+ B cells: Use of B cell lineage trees to delineate their role in the pathogenesis of light chain amyloidosis" [Clin. Immunol. 120 (2006) 106-120] (DOI:10.1016/j.clim.2006.01.008)

Manske, M. K., Zuckerman, N. S., Timm, M. M., Maiden, S., Edelman, H., Shahaf, G., Barak, M., Dispenzieri, A., Gertz, M. A., Mehr, R. & Abraham, R. S., Mar 1 2007, In : Clinical Immunology. 122, 3, 1 p.

Research output: Contribution to journalComment/debate

2006
1 Scopus citations